Microorganism |
MIC50 (μg/ml) |
MIC90 (μg/ml) |
Range (μg/ml) |
Antimicrobial |
Reference |
Staphylococcus aureus (12h) |
- |
- |
416 - ? |
Ochna natalitia (Acetone extract) |
1381 |
Staphylococcus aureus (12h) |
- |
- |
1250 - ? |
Ochna serullata (Acetone extract) |
1381 |
Staphylococcus aureus (13 + methicillin-resistant) |
- |
- |
0.25 - ? |
Dalbavancin |
72 |
Staphylococcus aureus (13 + methicillin-resistant) |
- |
- |
0.5 - ? |
Oritavancin (LY333328) |
207 |
Staphylococcus aureus (13 + methicillin-resistant) |
- |
- |
0.5 - ? |
Oritavancin (LY333328) |
72 |
Staphylococcus aureus (13 + methicillin-resistant) |
- |
- |
0.5 - ? |
Quinupristin/Dalfopristin (Synercid) |
207 |
Staphylococcus aureus (13 + methicillin-resistant) |
- |
- |
0.5 - ? |
Quinupristin/Dalfopristin (Synercid) |
72 |
Staphylococcus aureus (13 + methicillin-resistant) |
- |
- |
0.5 - ? |
Teicoplanin (Targocid) |
207 |
Staphylococcus aureus (13 + methicillin-resistant) |
- |
- |
0.5 - ? |
Teicoplanin (Targocid) |
72 |
Staphylococcus aureus (13 + methicillin-resistant) |
- |
- |
1 - ? |
LBM415 (NVP-PDF-713, VIC-10495) |
207 |
Staphylococcus aureus (13 + methicillin-resistant) |
- |
- |
1 - ? |
Vancomycin (Vancocyn, Lyphocin) |
207 |
Staphylococcus aureus (13 + methicillin-resistant) |
- |
- |
1 - ? |
Vancomycin (Vancocyn, Lyphocin) |
72 |
Staphylococcus aureus (13 + methicillin-resistant) |
- |
- |
2 - ? |
Daptomycin (Cubicin) |
207 |
Staphylococcus aureus (13 + methicillin-resistant) |
- |
- |
2 - ? |
Daptomycin (Cubicin) |
72 |
Staphylococcus aureus (13 + methicillin-resistant) |
- |
- |
2 - ? |
Linezolid (PNU-100766, U-100766, Zyvox) |
207 |
Staphylococcus aureus (13 + methicillin-resistant) |
- |
- |
2 - ? |
Linezolid (PNU-100766, U-100766, Zyvox) |
72 |
Staphylococcus aureus (13 + methicillin-resistant) |
- |
- |
2 - ? |
Ranbezolid (RBX 7644) |
72 |
Staphylococcus aureus (13 + methicillin-resistant) |
- |
- |
2 - ? |
Ranbezolid (RBX 7644) |
207 |
Staphylococcus aureus (13 + methicillin-resistant) |
- |
- |
4 - ? |
Moxifloxacin (BAY 12-8039, Avelox) |
207 |
Staphylococcus aureus (13 + methicillin-resistant) |
- |
- |
>32 - ? |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
207 |
Staphylococcus aureus (13 + methicillin-resistant) |
- |
- |
32 - ? |
Levofloxacin (Levaquin, Quixin) |
207 |
Staphylococcus aureus (131-6952X + linezolid-resistant) |
- |
- |
1 - ? |
TR-700 |
192 |
Staphylococcus aureus (131-6952X + linezolid-resistant) |
- |
- |
1 - ? |
Vancomycin (Vancocyn, Lyphocin) |
192 |
Staphylococcus aureus (131-6952X + linezolid-resistant) |
- |
- |
>2 - ? |
Oxacillin (Prostaphilin, Bactocil, Prostaphlin) |
192 |
Staphylococcus aureus (131-6952X + linezolid-resistant) |
- |
- |
32 - ? |
Linezolid (PNU-100766, U-100766, Zyvox) |
192 |
Staphylococcus aureus (13709 + methicillin-susceptible) |
- |
- |
0.25 - ? |
Nafcillin (Unipen, Nafcil) |
269 |
Staphylococcus aureus (13709 + methicillin-susceptible) |
- |
- |
1 - ? |
Telavancin (TD-6424, Vibativ) |
209 |
Staphylococcus aureus (13709 + methicillin-susceptible) |
- |
- |
1 - ? |
Vancomycin (Vancocyn, Lyphocin) |
269 |